
    
      PRIMARY OBJECTIVES:

      I. Estimate the change in antibody levels between years 10 and 15. II. Estimate the
      proportion of individuals who become seronegative (i.e.: serorevert) between years 10 and 15.

      OUTLINE:

      Patients complete a short questionnaire regarding risk factors for HPV infection and undergo
      collection of blood samples for testing HPV16 and HPV18 levels at years 13 and 15 after
      receiving initial vaccination.
    
  